Form 4 for CRL Charles River Laboratories
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-03 · accession 0001100682-26-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-03 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | P - Purchase | $174.54 | +25 | 27.4K | +0.1% | +$4,364 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | P | A | 25 | $174.54 | 27,448 | D | — | — |